A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder (Moonlight-1)

Last Updated   February 22, 2025

Want to learn how to participate in this trial?

89495120MDD2001

OVERVIEW

  • Sexes Eligible for Study
    all
  • Age
    18+ years
  • Phase
    phase 2
    2
  • Sites
    8 Sites
  • Status
     Recruiting

SUMMARY

The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).

CONDITIONS

  • Depressive Disorder, Major

ELIGIBILITY


Inclusion Criteria:

* Primary psychiatric diagnosis of recurrent major depressive disorder, without psychotic features, based on clinical assessment using diagnostic and statistical manual of mental disorders (DSM)-5 criteria and confirmed with the mini international neuropsychiatri

More...

DETAILS

LOCATIONS

Locations in:
United States
Country (1) City or Province (8) Status
United States Redlands Anderson Clinical Research
RECRUITING
United States Temecula Viking Clinical Research Ltd
RECRUITING
United States Walnut Creek Sunwise Clinical Research
RECRUITING
United States Fort Myers Gulfcoast Medical Research Center
RECRUITING
United States Pembroke Pines Best Choice Medical and Research Service
RECRUITING
United States Atlanta Synexus Clinical Research US Inc
RECRUITING
United States New Orleans DelRicht Research
RECRUITING
United States North Charleston Coastal Carolina Research Center
RECRUITING
Show More
Geo Locations

34.05557, -117.18254

33.49364, -117.14836

37.90631, -122.06496

26.62168, -81.84059

26.00315, -80.22394

33.749, -84.38798

29.95465, -90.07507

32.85462, -79.97481

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to individual site.

Interested in participating?